论文部分内容阅读
丙型肝炎病毒(HCV)是输血后肝炎的主要病原,也是散发性肝炎的常见原因。感染 HCV 后约有50%的人变为慢性肝炎。因此寻找有效的药物及方法治疗 HCV 是当务之急。本文用病毒唑、聚肌胞联合熊去氧胆酸(UDCA)治疗慢性丙型肝炎
Hepatitis C virus (HCV) is the major cause of post-transfusion hepatitis and is also a common cause of sporadic hepatitis. About 50% of people who become infected with HCV become chronic hepatitis. Therefore, looking for effective drugs and methods for the treatment of HCV is a priority. In this paper, ribavirin, polymyosin combined with ursodeoxycholic acid (UDCA) in the treatment of chronic hepatitis C